⌘K

Home/Filings/4/0001062993-22-005482

4//SEC Filing

Aklog Lishan 4

Accession 0001062993-22-005482

CIK 0001799011other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:13 PM ET

Size

5.1 KB

Accession

0001062993-22-005482

Insider Transaction Report

Form 4

Period: 2022-02-18

Lucid Diagnostics Inc.LUCD

DirectorChief Executive Officer

Transactions

Award
Employee stock option (right to buy)
2022-02-18+75,000→ 75,000 total
Exercise: $3.95Exp: 2032-02-18→ Common stock (75,000 underlying)

Footnotes (1)

[F1]The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Lucid Diagnostics Inc.

CIK 0001799011

Entity typeother

Related Parties

1

filerCIK 0001665074

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 8:13 PM ET
Size: 5.1 KB

View on SEC.gov